• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Luís Fernández-Morales, Miquel A. Seguí, +8 authors Eugeni Saigí
  • Medicine
  • Clinical breast cancer
  • 2007 (First Published: 1 April 2007)
  • PURPOSE In clinical practice, it is possible to classify breast tumors according to estrogen receptor (ER), progesterone receptor (PgR), and HER2 overexpression: ER negative, PgR negative, and HER2Continue Reading
  • Antonio Llombart-cussac, Manuel Ramos, +15 authors Carlos Jara-Sánchez
  • Medicine
  • European journal of cancer
  • 2016 (First Published: 1 May 2016)
  • BACKGROUND Docetaxel-cyclophosphamide (TC) has become a common regimen in moderate-high-risk early breast cancer (EBC), but the incidence of chemotherapy-induced nausea and vomiting (CINV) with thisContinue Reading
  • Pedro Sánchez-Rovira, Miguel Ángel Seguí, +10 authors Juan R De la Haba-Rodríguez
  • Medicine
  • Clinical and Translational Oncology
  • 2013 (First Published: 1 October 2013)
  • PurposeThe primary aim of this trial was to assess the rate of pathologic complete responses (pCR) of doxorubicin/cyclophosphamide (AC) followed by bevacizumab/docetaxel (BT), as neoadjuvant therapyContinue Reading
  • Luís Fernández-Morales, Elsa Dalmau, +7 authors Miguel Angel Seguí-Palmer
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006
  • 626 Background: The determination of ER and PR has a considerable importance when evaluating the prognosis and the response to treatment in breast cancer (BC). Assessment of HER2 status is also aContinue Reading